Definitive Contract 75D30119C06702
Award Date 9/18/19
Potential Completion Date 10/9/22
Potential Value $312K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Denver, CO 80204, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $3.78M to Denver Health and Hospital Authority for tuberculosis trials and consortium services. The contract, effective January 1, 2021, and extending through December 31, 2030, supports clinical research activities under the CDC's broader tuberculosis prevention and treatment initiatives. Denver Health will serve as a participating site in the Tuberculosis Trials Consortium, conducting...
- This $3,015,216.50 Delivery Order contract was awarded to Denver Health and Hospital Authority (Denver Health) by the Centers for Disease Control and Prevention (CDC) to provide Vaccine Safety Datalink (VSD) services. The VSD is an IDIQ contract vehicle managed by the CDC to support ongoing vaccine safety monitoring and research. This award does not have a set-aside designation. As a 555-bed academic health system and the region's only Level I trauma center, Denver Health provides...
- This is a $1,353,024.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Denver Health and Hospital Authority, doing business as Denver Health, to harness diverse data through information sciences to improve health outcomes, evaluate bias, recruitment, and retention in an online setting, conduct a recruitment and retention optimization study, and perform content validation of questionnaire modules. The contract supports a pilot study for these...
- Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...
- This is a federal contract awarded by the Department of Health and Human Services' Food and Drug Administration to the Denver Health and Hospital Authority. The $427,972.40 contract is for a "DATA ENHANCEMENT PROJECT" to support the FDA's post-marketing prescription and over-the-counter drug abuse surveillance data. The work is being performed under the FDA Prescription Drug Abuse Summary Reports contract vehicle. The contract does not have a set-aside designation. As a U.S. local...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,434,867.00 definitive cost-no-fee contract to The Johns Hopkins University to support the Tuberculosis Trials Consortium (TBTC). This contract, which does not have a set-aside designation, was awarded on September 18, 2019 and has a completion date of March 17, 2021. The Johns Hopkins University, a private non-profit research university, will provide clinical trial and data coordination services...
- This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...
- The Regents of the University of Colorado, doing business as University of Colorado-Denver, received a $2.22M firm fixed-price definitive contract from the Centers for Disease Control and Prevention (CDC) on September 18, 2023, for work under Broad Agency Announcement FY23 Topic 35. The contract, which has no set-aside designation, is scheduled for completion on October 17, 2026, and will be performed in Aurora, Colorado. As a major public research institution, University of Colorado-Denver...
- This is a $5,176,985.37 cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County. The contract is to develop, implement, and evaluate interventions to improve identification and treatment of latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. The contract is part of the TBESC 3 - Seattle and King County program and does not have a...
- This is a firm fixed-price purchase order awarded by a civilian federal agency to the Denver Health and Hospital Authority, a U.S. local government entity. The $249,999.99 contract is for the purpose of launching a survey focused on tracking changing motivations and contextual factors associated with the use of psychedelics/hallucinogens. The award has no set-aside designation. Denver Health and Hospital Authority is a comprehensive healthcare system with extensive experience in data collection,...